Printer Friendly

T-PA as stroke treatment?

Tissue plasminogen activator (t-PA), a clot-busting enzyme that is showing value in reducing damage after heart attacks (SN: 4/13/85, p. 229), may someday prove useful in stroke patients as well. Both strokes and heart attacks can occur when a clot lodges in a blood vessel, blocking blood flow. In the Dec. 13 SCIENCE researchers from the University of California's San Diego campus and University of Massachusetts in Worcester report the enzyme effectively protects rabbits from the neurological damage that occurs when a blood clot is induced in the brain; proper dosage information and proven efficacy with larger clots will be needed before the procedure can be tried on human patients, they say.
COPYRIGHT 1985 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1985, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:tissue plasminogen activator
Publication:Science News
Date:Dec 14, 1985
Previous Article:The texture of clinging proteins.
Next Article:Babymaking: expanding horizons.

Related Articles
Fortifying a protein through family ties.
New therapies brighten stroke horizon.
Sizing up the risks of heart-saving drugs.
Bold aim in stroke: spare the brain.
Compound in bat saliva may aid stroke patients. (Nifty Spittle).
Bagdade bags title, but Irish just short.
Colts' Omlid claims 5A girls title.
Who's really in charge? Physician assistants and nurse practitioners are common in health care facilities. But how much responsibility do they have?...
Cells' root: adult stem cells have a master gene.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters